Biofrontera

Biofrontera Treasury Stock

The Treasury Stock of Biofrontera (B8FK.DE) as of Nov 21, 2026 is 137.50 M EUR. In the previous year, Treasury Stock was 137.50 M EUR — a change of 0.00% (lower).

Treasury Stock

137.50 MEUR

YoY

0.00%

Last updated:

Treasury Stock of Biofrontera is 2025 137.50 M EUR. Treasury Stock of Biofrontera was 2024 137.50 M EUR. It decreases by 0.00% lower compared to the previous year.

The Biofrontera Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2015
0.69 EUR
Jan 1, 2016
0.00 EUR
Jan 1, 2022
137.32 M EUR
Jan 1, 2023
137.33 M EUR
Jan 1, 2024
137.50 M EUR
Jan 1, 2025
137.50 M EUR
The Biofrontera Treasury Stock history
YEARTreasury StockYoY
137.50 MEUR0.00%
137.50 MEUR+0.12%
137.33 MEUR+0.01%
137.32 MEUR—
0.00EUR-100.00%
0.69EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Biofrontera Stock analysis

What does Biofrontera do? Biofrontera AG generates revenue by developing, selling, and distributing dermatological drugs and medical cosmetics for skin care, protection, and treatment. The company markets its portfolio which includes Ameluz for the photodynamic therapy of actinic keratoses, the PDT lamp BF-RhodoLED used in conjunction with Ameluz treatment, and Belixos, a herbal dermatological cream for conditions such as insect bites, burns, neurodermatitis, and psoriasis. These products address the needs of patients and healthcare providers seeking treatments for skin diseases and regenerative care of damaged skin. The firm also engages in the clinical development of drug candidates to expand its future revenue streams. This includes BF-derm1, a tablet containing an inhibitor that blocks histamine synthesis to prevent allergic reactions, and BF1, a selective serotonin receptor agent aimed at preventing migraines. Through its five wholly owned subsidiaries, notably B, Biofrontera AG supports these development and distribution activities from its headquarters in Leverkusen, Nordrhein-Westfalen. Biofrontera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Biofrontera stock

Treasury Stock of Biofrontera is 137.50 M EUR in 2025.

Treasury Stock of Biofrontera changed from 137.50 M EUR to 137.50 M EUR, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Biofrontera since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Biofrontera historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Biofrontera

All Key Metrics — Biofrontera